China's FDA Issues Revised GMP Draft Guideline Following Industry Comments; Expects Compliance To Come In Stages
This article was originally published in The Pink Sheet Daily
Executive Summary
"It will be interesting to see how much of a grace period is given for manufacturers to meet standards, or whether certain manufacturers will be 'grandfathered' under old rules," industry consultant says.